DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lanreotide
Lanreotide
Drug Code List
Pharmacological Management of Acromegaly: a Current Perspective
To Download a List of Prescription Drugs Requiring Prior Authorization
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
Regulatory Mechanisms of Somatostatin Expression
Hypothalamic-Pituitary Axes
And Signifor LAR (Pasireotide) Prior Authorization with Quantity Limit
A Comparison Between Octreotide-LAR and Lanreotide-SR in the Chronic Treatment of Acromegaly
Developing Synthetic Peptide-Based Inhibitors of Human Growth Hormone Receptor
Jcem2957.Pdf
V3.23 Durable Medical Equipment, Supplies, Vision and Hearing Hardware Nationwide by HCPCS Code
Acromegaly Caused by a Growth Hormone- Releasing Hormone Secreting Carcinoid Tumour of the Lung: the Effect of Octreotide Treatment
How Are Growth Hormone and Insulin-Like Growth Factor-1 Reported As Markers for Drug Effectiveness in Clinical Acromegaly Resear
Michigan Department of Health and Human Services Practitioner and Medical Clinic Fee Schedule April
Pituitary Disorders
2020 Aetna Standard Plan
Patient Information
Exhibit #4 Effective 1/1/2014
Top View
Appendix B - Product Name Sorted by Applicant
Lanreotide (Somatuline® Depot) Prior Authorization Drug Coverage Policy
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling
203255Orig1s000
Michigan Department of Health and Human Services
Lanreotide) INJECTION (5.1) Initial U.S
1 Diseases of Endocrine System. Hypothalamic
FEP 5 Tier Rx Drug Formulary (607) Standard Option
Successful Treatment of Resistant Acromegaly with a Growth Hormone Receptor Antagonist
Somatostatin Analogs in Clinical Practice: a Review
Somatostatin Receptor Subtype Specificity in Human Fetal Pituitary Cultures. Differential Role of SSTR2 and SSTR5 for Growth
Signifor, INN-Pasireotide
2017 New Drug Therapy Approvals Report
Prior Authorization Criteria 2021 PWAG Last Updated: 10/01/2021
View Our Specialty Medication List
Somatostatin Analogues (Somatuline LA, Somatuline Autogel and Sandostatin LAR)
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of 177Lu-DOTA-Octreotate in Neuro
Variable Growth Hormone Profiles Following Withdrawal of Long-Term 30 Mg Slow-Release Lanreotide Treatment in Acromegalic Patien
Advances in Therapeutic Peptides Targeting G Protein-Coupled Receptors
Mandatory Specialty Drug List
MANAGEMENT of ENDOCRINE DISEASE: Acromegaly and Pregnancy: a Contemporary Review
And Lanreotide (Somatuline Autogel, Somatuline LA ®) Unlicensed Use in Secretory Gastrointestinal Disorders (E.G
Pituitary Tumors
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
SOMATULINE® DEPOT (Lanreotide) INJECTION Adjusted Accordingly (5.2) Initial U.S
Clinical Utility of Lanreotide Autogel® in Gastroenteropancreatic Neuroendocrine Tumors
Lanreotide for the Treatment of Neuroendocrine Tumours: a Review of Clinical Effectiveness, Cost- Effectiveness, and Guidelines
Acromegaly: an Endocrine Society Clinical Practice Guideline
Regulatory Issues Concerning the Preclinical Testing of Synthetic Peptides
Growth Hormone Levels in Patients with Active Acromegaly Treated with Somatostatin Analogues
AHFS Pharmacologic-Therapeutic Classification System
2020 Table of Drugs
The Role of Counter-Ions in Peptides—An Overview
Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Trafficking in Vitro
View the Specialty Pharmacy 1199 SEIU Drug List
Accepted Manuscript
Pasireotide for Uncontrolled Acromegaly—New Phase III
Somatostatin and Its Analog Lanreotide Inhibit the Proliferation of Dispersed Human Non-Functioning Pituitary Adenoma Cells in Vitro
Neuroendocrine Tumours
Growth, Growth Hormone, & Metabolism
The Conversion of Short Acting Octreotide to Long Acting Lanreotide
Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational 2 Analysis for Repurposing Against COVID-19
2016 Table of Drugs
Phase III Study of Pasireotide in Patients with Inadequately Controlled Acromegaly
V3.21 Durable Medical Equipment, Supplies, Vision and Hearing